SCHEMBL6974155

SCHEMBL6974155

COC(=O)c1ccc(S(=O)(=O)Nc2ccc(F)cc2)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.55
HPGD P15428 3/20 0.55
PKM P14618 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 2/20 0.53
CYP1A2 P05177 1/20 0.53
GLA P06280 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
RECQL P46063 1/20 0.53
HTT P42858 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
ATM Q13315 2/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30230013 0.81 P2RX1 (0.48) LMNAHPGDPKMCYP2C9HTT
SCHEMBL15772389 0.79 MAPT (0.70) LMNAHPGDMEN1KMT2AALDH1A1
SCHEMBL6977966 0.79 MAPT (0.70) LMNAHPGDMEN1KMT2AALDH1A1
SCHEMBL16353893 0.78 MAPT (0.68) LMNAHPGDMEN1KMT2AALDH1A1
SCHEMBL16469334 0.78 ALDH1A1 (0.49) LMNAHPGDALDH1A1HTTPOLB
SCHEMBL15359749 0.78 PTK2B (0.50) LMNAHPGDPKMALDH1A1HTT
SCHEMBL6978287 0.76 CYP2C9 (0.64) LMNAHPGDPKMKMT2AALDH1A1
SCHEMBL6979884 0.76 PLAU (0.53) LMNAHPGDMEN1KMT2AALDH1A1
SCHEMBL6971665 0.76 HTT (0.54) LMNAHPGDPKMMEN1KMT2A
SCHEMBL12492782 0.75 VCAM1 (0.61) HPGDPKMALDH1A1CYP1A2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed